Endocrine influences on human mammary cancer formation. A critique.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000728:Androgens / Q000652:urine*; D000738:Androsterone / Q000652:urine; D000818:Animals; D001665:Binding Sites; D001941:Breast Diseases / Q000652:urine; D001943:Breast Neoplasms / Q000209:etiology* / Q000652:urine; D002369:Castration; D004958:Estradiol / Q000096:biosynthesis; D004964:Estriol / Q000652:urine; D004965:Estrogen Antagonists; D004967:Estrogens / Q000652:urine*; D004970:Estrone / Q000096:biosynthesis; D005043:Etiocholanolone / Q000652:urine; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000652:urine; D007037:Hypothyroidism / Q000652:urine; D000860:Hypoxia / Q000652:urine; D008593:Menopause; D051379:Mice; D009765:Obesity / Q000652:urine; D011247:Pregnancy; D051381:Rats; D013312:Stress, Physiological / Q000652:urine
D000728:Androgens; D004965:Estrogen Antagonists; D004967:Estrogens; D004970:Estrone; D004958:Estradiol; D000324:Adrenocorticotropic Hormone; D005043:Etiocholanolone; D000738:Androsterone; D004964:Estriol